Charles Li
Director/Board Member at EKSO BIONICS HOLDINGS, INC.
Net worth: 37 275 $ as of 2024-03-30
Profile
Charles Li is currently an Independent Director at Ekso Bionics Holdings, Inc. and the Chief Business Officer at Angel Pharmaceuticals Co., Ltd.
He holds a doctorate degree from Harvard University and an undergraduate degree from Xi'an Jiaotong University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-04-13 | 27,408 ( 0.15% ) | 37 275 $ | 2024-03-30 |
Charles Li active positions
Companies | Position | Start |
---|---|---|
EKSO BIONICS HOLDINGS, INC. | Director/Board Member | 2018-03-10 |
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Corporate Officer/Principal | 2020-10-09 |
Training of Charles Li
Harvard University | Doctorate Degree |
Xi'an Jiaotong University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
EKSO BIONICS HOLDINGS, INC. | Health Technology |
Private companies | 1 |
---|---|
Angel Pharmaceuticals Co., Ltd.
Angel Pharmaceuticals Co., Ltd. BiotechnologyHealth Technology Angel Pharmaceuticals Co., Ltd. operates as a biopharmaceutical company which develops medicines for treatment of cancer, autoimmune and infectious diseases. The company was founded by Richard Miller and Ted Wang on October 5, 2020 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Charles Li